233 related articles for article (PubMed ID: 23948549)
1. Up-regulation of pro-angiogenic factors and establishment of tolerance in malignant pleural effusions.
Lieser EA; Croghan GA; Nevala WK; Bradshaw MJ; Markovic SN; Mansfield AS
Lung Cancer; 2013 Oct; 82(1):63-8. PubMed ID: 23948549
[TBL] [Abstract][Full Text] [Related]
2. The local cytokine and chemokine milieu within malignant effusions.
Atanackovic D; Cao Y; Kim JW; Brandl S; Thom I; Faltz C; Hildebrandt Y; Bartels K; de Weerth A; Hegewisch-Becker S; Hossfeld DK; Bokemeyer C
Tumour Biol; 2008; 29(2):93-104. PubMed ID: 18515987
[TBL] [Abstract][Full Text] [Related]
3. Sestrin-2 is significantly increased in malignant pleural effusions due to lung cancer and is potentially secreted by pleural mesothelial cells.
Tsilioni I; Filippidis AS; Kerenidi T; Budanov AV; Zarogiannis SG; Gourgoulianis KI
Clin Biochem; 2016 Jun; 49(9):726-728. PubMed ID: 26874199
[TBL] [Abstract][Full Text] [Related]
4. Prognostic values of VEGF and endostatin with malignant pleural effusions in patients with lung cancer.
Zhang Y; Yu LK; Lu GJ; Xia N; Xie HY; Hu W; Hao KK; Xu CH; Qian Q
Asian Pac J Cancer Prev; 2014; 15(19):8435-40. PubMed ID: 25339042
[TBL] [Abstract][Full Text] [Related]
5. T-helper type 1/T-helper type 2 balance in malignant pleural effusions compared to tuberculous pleural effusions.
Okamoto M; Hasegawa Y; Hara T; Hashimoto N; Imaizumi K; Shimokata K; Kawabe T
Chest; 2005 Dec; 128(6):4030-5. PubMed ID: 16354877
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions.
Duysinx BC; Corhay JL; Hubin L; Nguyen D; Henket M; Louis R
Respir Med; 2008 Dec; 102(12):1708-14. PubMed ID: 18760578
[TBL] [Abstract][Full Text] [Related]
7. A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.
Stathopoulos GT; Psallidas I; Moustaki A; Moschos C; Kollintza A; Karabela S; Porfyridis I; Vassiliou S; Karatza M; Zhou Z; Joo M; Blackwell TS; Roussos C; Graf D; Kalomenidis I
J Natl Cancer Inst; 2008 Oct; 100(20):1464-76. PubMed ID: 18840818
[TBL] [Abstract][Full Text] [Related]
8. Profile of Metalloproteinases and Their Association with Inflammatory Markers in Pleural Effusions.
Teixeira LR; Dias MB; Sales RK; Antonangelo L; Alvarenga VA; Puka J; Marchi E; Acencio MM
Lung; 2016 Dec; 194(6):1021-1027. PubMed ID: 27677622
[TBL] [Abstract][Full Text] [Related]
9. Metabonomics by proton nuclear magnetic resonance in human pleural effusions: A route to discriminate between benign and malignant pleural effusions and to target small molecules as potential cancer biomarkers.
Zennaro L; Vanzani P; Nicolè L; Cappellesso R; Fassina A
Cancer Cytopathol; 2017 May; 125(5):341-348. PubMed ID: 28140518
[TBL] [Abstract][Full Text] [Related]
10. The role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusion.
Bradshaw M; Mansfield A; Peikert T
Curr Oncol Rep; 2013 Jun; 15(3):207-16. PubMed ID: 23568600
[TBL] [Abstract][Full Text] [Related]
11. High level of vascular endothelial growth factor in hemorrhagic pleural effusion of cancer.
Ishimoto O; Saijo Y; Narumi K; Kimura Y; Ebina M; Matsubara N; Asou N; Nakai Y; Nukiwa T
Oncology; 2002; 63(1):70-5. PubMed ID: 12187074
[TBL] [Abstract][Full Text] [Related]
12. Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions.
Hamed EA; El-Noweihi AM; Mohamed AZ; Mahmoud A
Respirology; 2004 Mar; 9(1):81-6. PubMed ID: 14982607
[TBL] [Abstract][Full Text] [Related]
13. Cytokine/Chemokine/Growth Factor Levels in Malignant Pleural Effusion of Non-small Cell Lung Cancer.
Hayama N; Hattori S; Takahashi G; Takahashi F; Takeuchi T; Tanaka J; Horio Y; Takiguchi H; Tomomatsu K; Kitahara A; Takihara T; Niimi K; Oguma T; Asano K
Tokai J Exp Clin Med; 2020 Dec; 45(4):224-229. PubMed ID: 33300594
[TBL] [Abstract][Full Text] [Related]
14. Mast cells mediate malignant pleural effusion formation.
Giannou AD; Marazioti A; Spella M; Kanellakis NI; Apostolopoulou H; Psallidas I; Prijovich ZM; Vreka M; Zazara DE; Lilis I; Papaleonidopoulos V; Kairi CA; Patmanidi AL; Giopanou I; Spiropoulou N; Harokopos V; Aidinis V; Spyratos D; Teliousi S; Papadaki H; Taraviras S; Snyder LA; Eickelberg O; Kardamakis D; Iwakura Y; Feyerabend TB; Rodewald HR; Kalomenidis I; Blackwell TS; Agalioti T; Stathopoulos GT
J Clin Invest; 2015 Jun; 125(6):2317-34. PubMed ID: 25915587
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions.
Zebrowski BK; Yano S; Liu W; Shaheen RM; Hicklin DJ; Putnam JB; Ellis LM
Clin Cancer Res; 1999 Nov; 5(11):3364-8. PubMed ID: 10589746
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor and soluble intercellular adhesion molecule-1 in lung adenocarcinoma with malignant pleural effusion: correlations with patient survival and pleural effusion control.
Qian Q; Zhan P; Sun WK; Zhang Y; Song Y; Yu LK
Neoplasma; 2012; 59(4):433-9. PubMed ID: 22489699
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of soluble B7-H3 in NSCLC-derived malignant pleural effusion: A potential diagnostic biomarker correlated with NSCLC staging.
Chen L; Zhang G; Sheng S; Zhou Q; Pan Y; Guan S
Clin Chim Acta; 2016 Jun; 457():81-5. PubMed ID: 27071700
[TBL] [Abstract][Full Text] [Related]
18. Migrated T lymphocytes into malignant pleural effusions: an indicator of good prognosis in lung adenocarcinoma patients.
Nieto JC; Zamora C; Porcel JM; Mulet M; Pajares V; Muñoz-Fernandez AM; Calvo N; Espinosa I; Pascual-García M; Bielsa S; Vidal S
Sci Rep; 2019 Feb; 9(1):2996. PubMed ID: 30816121
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor in malignant and tuberculous pleural effusions.
Lim SC; Jung SI; Kim YC; Park KO
J Korean Med Sci; 2000 Jun; 15(3):279-83. PubMed ID: 10895968
[TBL] [Abstract][Full Text] [Related]
20. [Vascular endothelial growth factor in benign and malignant pleural effusions].
Kaya A; Poyraz B; Celik G; Ciledag A; Gulbay BE; Savas H; Savas I
Arch Bronconeumol; 2005 Jul; 41(7):376-9. PubMed ID: 16029730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]